Traditional Chinese medicine composition for treating anxiety disorder

Through traditional Chinese medicine compositions of turmeric, gardenia, lotus seeds, green stones, chicken gizzards and jujube seeds, the addiction, drug resistance and side effects of existing anxiety treatment drugs are solved, and the rapid and effective anxiety disorders are achieved The therapeutic effect avoids the occurrence of drug dependence and side effects.

CN118903352AActive Publication Date: 2024-11-08孙文军
View PDF 3 Cites 0 Cited by

Patent Information

Application Number
CN202411234821.1
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-09-04
Publication Date
2024-11-08
Estimated Expiration
2044-09-04

AI Technical Summary

Technical Problem

Existing anxiety treatment drugs have problems with excessive sedation, addiction, drug resistance and side effects, which are difficult to fundamentally cure anxiety, and their efficacy is difficult to maintain, resulting in rekindling or recurrence.

Method used

The traditional Chinese medicine compositions of turmeric, gardenia, lotus seeds, green stones, chicken gizzards, and jujube kernels are prepared into various dosage forms through decoction extraction, reflux extraction, impregnation extraction, etc., which are used to improve anxiety symptoms and avoid drugs. Dependence and side effects.

Benefits of technology

Effectively improve the mental and physical symptoms of anxiety patients, significantly improve the treatment effect, avoid side effects such as excessive sedation, dizziness, extrapyramidal reactions, and show efficacy in the short term, and there is no risk of drug dependence on long-term use.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure SMS_1
    Figure SMS_1
  • Figure SMS_2
    Figure SMS_2
Patent Text Reader

Abstract

The invention provides a traditional Chinese medicine composition for treating anxiety disorder. The traditional Chinese medicine composition is prepared from radix curcumae, fructus gardeniae, lotus seeds, lapis chloriti, endothelium corneum gigeriae galli and spina date seeds. Clinical research shows that the anti-anxiety effective rate of the traditional Chinese medicine composition group in the second week is 64%, and the anti-anxiety effective rate is obviously superior to that of paroxetine hydrochloride in the traditional western medicine; when the test is finished, the total effective rate of the traditional Chinese medicine composition reaches 75.2% and is obviously improved compared with that of paroxetine hydrochloride as an anti-anxiety western medicine; the traditional Chinese medicine composition does not have any side effect after being taken.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present application relates to a Chinese medicine composition for treating anxiety, belonging to the technical field of traditional Chinese medicine. Background Art

[0002] Anxiety disorder is a mental disorder with anxiety syndrome as the main clinical manifestation. Anxiety disorder manifests itself in mental symptoms and physical symptoms. Mental symptoms refer to an inner experience of worry, fear and anxiety, accompanied by nervousness and uneasiness; physical symptoms are symptoms of autonomic nervous system hyperfunction accompanied by mental symptoms, such as palpitations, chest tightness, shortness of breath, dry mouth, sweating, muscle tension tremors, tremors, facial flushing or pallor, etc. The lifetime prevalence of anxiety disorders is 13.6% to 28.8%, the annual prevalence is 5.6% to 19.3%, and it has a high comorbidity rate. 43.5% of anxiety patients are accompanied by depressive episodes, which seriously affect the quality of life of patients.

[0003] Modern medicine has many treatment modes and methods for anxiety disorders, but most of them can be classified into two modes: biological treatment and psychosocial treatment. Biological treatment includes: drug therapy, electroconvulsive therapy, phototherapy, etc.; psychosocial treatment includes: supportive psychotherapy, psychodynamic therapy, interpersonal relationship therapy, cognitive behavioral therapy, marriage and family therapy, art therapy, etc. Anti-anxiety drug treatment is the main means of clinical treatment of anxiety disorders. SSRI antidepressants and benzodiazepines are the first-line clinical treatment drugs. They often have excessive sedation, gastrointestinal reactions, and cardiovascular reactions. SSRI drugs take 2 to 3 weeks to take effect and need to be taken for a long time to maintain the effect. Although benzodiazepines take effect quickly, the effect is difficult to maintain. They need to be taken for a long time to maintain the anti-anxiety effect. Long-term use is prone to addiction or drug resistance, which often leads to long-term use and drug addiction. It will also cause excessive sedation, dizziness, slow reaction, and cognitive impairment. Severe anxiety patients can also be treated with low doses of anti-epileptic drugs and antipsychotic drugs. Long-term use of the former often leads to abnormal liver function or drug-induced rash, while the latter is prone to extrapyramidal symptoms such as involuntary movements and tremors. Moreover, after discontinuation of the above drugs, anxiety often relapses or relapses, making it difficult to cure them fundamentally. Summary of the invention

[0004] In order to solve the problems existing in the prior art, the present invention provides a Chinese medicine composition for treating anxiety and application of the Chinese medicine composition in preparing a medicine for treating anxiety.

[0005] As one aspect of the present invention, the present invention provides a traditional Chinese medicine composition for treating anxiety, wherein the traditional Chinese medicine composition is prepared from turmeric, gardenia, lotus seeds, qinglun stone, chicken gizzard lining and spiny jujube seeds.

[0006] Preferably, the Chinese medicine composition is made of the following raw materials in parts by weight: 10-40 parts by weight of Curcuma, 7-28 parts by weight of Gardenia, 7-28 parts by weight of Lotus Seed, 16-64 parts by weight of Celadonite, 4-18 parts by weight of Chicken Gizzard Stone, and 16-64 parts by weight of Semen Ziziphi Spinosae.

[0007] Further preferably, the Chinese medicine composition is made of the following raw materials in parts by weight: 15-30 parts by weight of Curcuma, 10-20 parts by weight of Gardenia, 10-20 parts by weight of Lotus Seed, 22-44 parts by weight of Celadonite, 6-14 parts by weight of Chicken Gizzard Stone, and 22-44 parts by weight of Semen Ziziphi Spinosae.

[0008] Further preferably, the Chinese medicine composition is made of the following raw materials in parts by weight: 18-27 parts by weight of Curcuma, 12-18 parts by weight of Gardenia, 12-18 parts by weight of Lotus Seed, 26-39 parts by weight of Celadonite, 8-12 parts by weight of Chicken Gizzard Stone, and 26-39 parts by weight of Ziziphus jujuba seed.

[0009] Most preferably, the Chinese medicine composition is made of the following raw materials in parts by weight: 20 parts by weight of Curcuma, 15 parts by weight of Gardenia, 15 parts by weight of Lotus Seed, 30 parts by weight of Greenstone, 10 parts by weight of Chicken Gizzard Stone, and 30 parts by weight of Ziziphus jujuba seed.

[0010] The Chinese medicine composition of the present invention can be a composition formed by mixing the raw materials after crushing, or an extract obtained by mixing or extracting the raw materials separately, or an effective part obtained by further refining and purifying the extract, or a conventional dosage form prepared by adding pharmaceutically acceptable excipients to the extract / effective part.

[0011] Among them, the extraction method includes decoction extraction, reflux extraction, immersion extraction, ultrasonic extraction, percolation extraction, microwave extraction, etc.; the extraction solvent includes one or more of water, methanol, 20-95% ethanol solution, and acetone; the purification method includes water extraction and alcohol precipitation, alkali dissolution and acid precipitation, and various column chromatography purification methods, such as macroporous resin columns, silica gel columns, gel columns, reverse phase columns, etc.; the conventional dosage forms include but are not limited to injections, capsules, tablets, granules, gels, sustained-release agents, oral liquids, pills or nano preparations; the pharmaceutically acceptable excipients include: fillers, disintegrants, lubricants, suspending agents, adhesives, sweeteners, flavoring agents, preservatives, matrices, etc. Fillers include: starch, pregelatinized starch, lactose, mannitol, chitin, microcrystalline cellulose, sucrose, etc.; disintegrants include: starch, pregelatinized starch, microcrystalline cellulose, sodium carboxymethyl starch, cross-linked polyvinyl pyrrolidone, low-substituted hydroxypropyl cellulose, cross-linked sodium carboxymethyl cellulose, etc.; lubricants include: magnesium stearate, sodium lauryl sulfate, talc, silicon dioxide, etc.; suspending agents include: polyvinyl pyrrolidone, microcrystalline cellulose, sucrose, agar, hydroxypropyl methylcellulose, etc.; binders include starch slurry, polyvinyl pyrrolidone, hydroxypropyl methylcellulose, etc.

[0012] As another aspect of the present invention, the Chinese medicine composition of the present invention can also be made of the extract of the raw material medicine as a raw material. Therefore, the present invention further provides a Chinese medicine composition for treating anxiety, wherein the Chinese medicine composition is made of the following raw materials:

[0013] 10-40 parts by weight of Curcuma extract, 7-28 parts by weight of Gardenia extract, 7-28 parts by weight of Lotus seed extract, 16-64 parts by weight of Celadonite extract, 4-18 parts by weight of Chicken Gizzard Stone Extract, and 16-64 parts by weight of Ziziphus jujuba seed extract.

[0014] Further preferably, the Chinese medicine composition is made of the following raw materials in parts by weight: 15-30 parts by weight of Curcuma extract, 10-20 parts by weight of Gardenia extract, 10-20 parts by weight of Lotus seed extract, 22-44 parts by weight of Celadonite extract, 6-14 parts by weight of Chicken Gizzard Stone Extract, and 22-44 parts by weight of Ziziphus jujuba seed extract.

[0015] Further preferably, the Chinese medicine composition is made of the following raw materials in parts by weight: 18-27 parts by weight of Curcuma extract, 12-18 parts by weight of Gardenia extract, 12-18 parts by weight of Lotus seed extract, 26-39 parts by weight of Celadonite extract, 8-12 parts by weight of Chicken Gizzard Stone Extract, and 26-39 parts by weight of Ziziphus jujuba seed extract.

[0016] Most preferably, the Chinese medicine composition is made of the following raw materials in parts by weight: 20 parts by weight of Curcuma extract, 15 parts by weight of Gardenia extract, 15 parts by weight of Lotus seed extract, 30 parts by weight of Celadon extract, 10 parts by weight of Chicken Gizzard Extract, and 30 parts by weight of Ziziphus jujuba seed extract.

[0017] The above extracts can be water extracts of the respective raw materials, or organic solvent extracts, or refined products obtained by further refining and purification of the water extracts / organic solvent extracts.

[0018] The organic solvent is selected from one or more of methanol, 20-95% ethanol solution, and acetone;

[0019] The extraction method used to prepare the above extract includes any one of reflux extraction, maceration extraction, ultrasonic extraction or percolation extraction, or a combination of different extraction methods.

[0020] As another aspect of the present invention, the present invention also provides the use of the traditional Chinese medicine composition in preparing a medicine for treating anxiety.

[0021] Beneficial effects of the Chinese medicine composition of the present invention:

[0022] The invention can effectively improve the mental anxiety and physical anxiety symptoms of anxiety patients through the combination of turmeric, gardenia, lotus seed, qinglun stone, chicken gizzard lining and spiny jujube seed, and can effectively avoid toxic and side effects such as excessive sedation, dizziness, extrapyramidal reaction, drug dependence and drug tolerance.

[0023] The principle of the prescription of the Chinese medicine composition of the present invention: Anxiety is mostly caused by emotional depression and liver depression, so the key to calming down is to relieve depression first. Therefore, the main ingredient of this prescription is Curcuma, which is bitter and cold in nature, soothes the liver and relieves depression, so that the liver can be relieved, and the triple burner qi is smooth. If the upper burner qi is smooth, the chest and ribs will not swell; if the middle burner qi is smooth, the stomach will not swell; if the lower burner qi is smooth, the bowel movement will be self-regulated. The second is to clear heat, so Gardenia is bitter and cold to clear heat, relieve restlessness and calm the mind. If the heart fire is cleared, the mood will be calm, the restlessness will be reduced, and the depression will be relieved. If the liver fire is cleared, irritability, bitter and dry mouth, headache, red eyes, and tinnitus can all be improved. If the fire is depressed for a long time, it will inevitably damage the liver blood, so it is assisted by Ziziphus jujuba seeds, which are sweet and flat in nature, enter the heart and liver meridians, are good at nourishing liver blood and restraining liver soul, and the two are ministerial drugs. Once the liver is overactive, it will inevitably attack the spleen. Lotus seeds are sweet, astringent and neutral, and are good at entering the heart and spleen. They can not only strengthen the spleen and stop diarrhea, but also nourish blood and calm the mind, which is the reason why they prevent the liver from attacking. When the heart and liver are hot, the mind and soul are uneasy, so the bluestone is sweet, salty and neutral in nature, and enters the heart and liver meridians. It can calm the mind and calm the mind, so the mind and soul are at peace, and the emotions are smooth, so it can calm the disorder of the mind and soul. The two are adjuvants. Chicken gizzard lining is sweet and neutral in nature. One is to strengthen the stomach to prevent the liver from attacking, and the other is to eliminate sand and gravel to prevent the bluestone from falling and hurting the stomach, which is the reason why it protects the stomach qi, so it can treat loss of appetite, noisy and acid regurgitation. All the medicines are used together to play the role of clearing the liver, purging fire, calming and calming the mind.

[0024] Clinical studies have shown that the anxiety efficacy of the Chinese medicine composition group of the present invention was 64% in the second week, which is significantly better than the traditional Western medicine paroxetine hydrochloride; at the end of the experiment, the total effective rate of the Chinese medicine composition of the present invention reached 75.2%, which is significantly higher than the anti-anxiety Western medicine paroxetine hydrochloride; no side effects such as dizziness, nausea and vomiting, abdominal distension and constipation, and weight gain were observed after taking the Chinese medicine composition of the present invention. DETAILED DESCRIPTION

[0025] The present invention is further described below by specific examples, and the present invention is not limited to the following examples. Within the scope of the present invention or without departing from the content, spirit and scope of the present invention, the changes, combinations or substitutions made to the present invention are obvious to those skilled in the art and are included in the scope of the present invention.

[0026] Example 1

[0027] Prescription: Curcuma 20g, Gardenia 15g, Lotus Seed 15g, Qinglan Stone 30g, Chicken Gizzard Stone 10g, Ziziphus jujuba seed 30g.

[0028] The raw materials are taken in proportion, crushed, boiled in water for extraction, and the extract is made into granules according to conventional processes.

[0029] Example 2

[0030] Prescription: Curcuma 19g, Gardenia 17g, Lotus Seed 13g, Qinglan Stone 35g, Chicken Gizzard Stone 9g, Ziziphus jujuba seed 35g.

[0031] The raw materials are taken in proportion, crushed, and made into capsules according to conventional preparation technology.

[0032] Example 3

[0033] Prescription: Curcuma 23g, Gardenia 13g, Lotus Seed 17g, Qinglan Stone 28g, Chicken Gizzard 11g, Ziziphus jujuba seed 28g.

[0034] The raw materials are taken in proportion, crushed, and made into tablets according to conventional preparation technology.

[0035] Example 4

[0036] Prescription: Curcuma 16g, Gardenia 19g, Lotus Seed 11g, Qinglan Stone 42g, Chicken Gizzard Stone 7g, Ziziphus jujuba seed 42g.

[0037] The raw materials are taken in proportion, crushed, and made into pills according to conventional preparation technology.

[0038] Example 5

[0039] Prescription: Curcuma 29g, Gardenia 11g, Lotus Seed 19g, Qinglan Stone 24g, Chicken Gizzard Stone 13g, Ziziphus jujuba seed 24g.

[0040] The raw materials are taken in proportion, boiled in water for extraction, and the decoction is made into oral liquid according to conventional preparation technology.

[0041] Example 6

[0042] Prescription: Curcuma 14g, Gardenia 22g, Lotus Seed 9g, Qinglan Stone 50g, Chicken Gizzard Stone 5g, Ziziphus jujuba seed 50g.

[0043] The raw materials are taken in proportion, boiled in water for extraction, and the decoction is made into granules according to conventional preparation technology.

[0044] Example 7

[0045] Prescription: Curcuma 32g, Gardenia 9g, Lotus Seed 22g, Qinglan Stone 20g, Chicken Gizzard Stone 15g, Ziziphus jujuba seed 20g.

[0046] The raw materials are taken according to the proportion, and 75% ethanol is added for reflux extraction, and the extract is made into capsules according to the conventional preparation process.

[0047] Example 8

[0048] Prescription: Curcuma 11g, Gardenia 26g, Lotus Seed 8g, Greenstone 62g, Chicken Gizzard 4g, Ziziphus jujuba seed 62g.

[0049] The raw materials are taken in proportion, and 75% ethanol is added for reflux extraction, and the extract is made into tablets according to conventional preparation technology.

[0050] Example 9

[0051] Prescription: Curcuma 38g, Gardenia 8g, Lotus Seed 26g, Qinglan Stone 18g, Chicken Gizzard Stone 17g, Ziziphus jujuba seed 18g.

[0052] The raw materials are taken in proportion, and 75% ethanol is added for reflux extraction, and the extract is made into pills according to conventional preparation technology.

[0053] Example 10

[0054] Formula: 20g of Curcuma extract, 15g of Gardenia extract, 15g of Lotus seed extract, 30g of Celadonite extract, 10g of Chicken Gizzard Extract, and 30g of Ziziphus jujuba seed extract.

[0055] Embodiment 11

[0056] Formula: 19g of Curcuma extract, 17g of Gardenia extract, 13g of Lotus seed extract, 35g of Celadonite extract, 9g of Chicken Gizzard Extract, and 35g of Ziziphus jujuba seed extract.

[0057] Example 12

[0058] Formula: Curcuma extract 23g, Gardenia extract 13g, Lotus seed extract 17g, Qingyanshi extract 28g, Chicken Gizzard Extract 11g, Ziziphus jujuba seed extract 28g.

[0059] Example 13

[0060] Formula: Curcuma extract 16g, Gardenia extract 19g, Lotus seed extract 11g, Qingyanshi extract 42g, Chicken Gizzard Extract 7g, Ziziphus jujuba seed extract 42g.

[0061] Embodiment 14

[0062] Formula: Curcuma extract 29g, Gardenia extract 11g, Lotus seed extract 19g, Greenstone extract 24g, Chicken gizzard extract 13g, Ziziphus jujuba seed extract 24g.

[0063] Embodiment 15

[0064] Formula: 14g of Curcuma extract, 22g of Gardenia extract, 9g of Lotus seed extract, 50g of Celadonite extract, 5g of Chicken Gizzard Extract, and 50g of Ziziphus jujuba seed extract.

[0065] Example 16

[0066] Formula: 32g of Curcuma extract, 9g of Gardenia extract, 22g of Lotus seed extract, 20g of Celadonite extract, 15g of Chicken Gizzard Extract, and 20g of Ziziphus jujuba seed extract.

[0067] Embodiment 17

[0068] Formula: 11g of Curcuma extract, 26g of Gardenia extract, 8g of Lotus seed extract, 62g of Celadonite extract, 4g of Chicken Gizzard Extract, and 62g of Ziziphus jujuba seed extract.

[0069] Embodiment 18

[0070] Formula: Curcuma extract 38g, Gardenia extract 8g, Lotus seed extract 26g, Qingyanshi extract 18g, Chicken Gizzard Extract 17g, Ziziphus jujuba seed extract 18g.

[0071] The extracts described in Examples 10-18 above are water extracts of the raw materials. The extracts are combined according to the formula amount and prepared into conventional oral dosage forms such as tablets, capsules, or granules according to conventional preparation processes.

[0072] Example 19 Prescription Screening Experiment

[0073] Prescription A: 20g of Curcuma, 15g of Gardenia, 15g of Lotus Seed, 30g of Green Stone, 10g of Chicken's Gizzard, 30g of Ziziphus jujuba seeds (Chinese medicine composition of the present invention);

[0074] Prescription B: 15g of Gardenia, 15g of Lotus Seed, 30g of Qingyan Stone, 10g of Chicken's Gizzard Endotheli, 30g of Ziziphus jujuba seeds (the main herb Curcuma is removed from the Chinese medicine composition of the present invention);

[0075] Formula C: Curcuma 20g, Scutellaria 10g, Lotus Seed 15g, Green Stone 30g, Chicken Gizzard 10g, Ziziphus jujuba seed 30g (the Chinese medicine composition of the present invention replaces the ministerial drug Gardenia);

[0076] For the above prescriptions, the raw materials are taken in proportion, decocted in water for extraction, and made into granules according to conventional processes.

[0077] A total of 60 patients with generalized anxiety disorder were observed and randomly divided into three groups, with 20 cases in each group. They were given group A, B, and C drug treatment respectively for a total of 4 weeks. The efficacy was evaluated using the generalized anxiety efficacy evaluation standard to observe the therapeutic effect of anxiety.

[0078] The effect of treatment was evaluated according to the Hamilton Anxiety Rating Scale reduction rate. The efficacy of the three groups was significantly different after 4 weeks of treatment. The effective rate of group A was 76.2% in the 4th week, the effective rate of group B was 62.2% in the 4th week, and the effective rate of group C was 65.4% in the 4th week. The difference among the three groups was significant (P<0.05), and the efficacy of group A>group C>group B.

[0079] The results showed that the efficacy of group A was significantly better than that of groups B and C. This indicates that the compatibility of the Chinese medicine composition of the present invention is optimal. When the main drug, Curcuma, is removed or the auxiliary drug, Gardenia, is replaced by other drugs, the compatibility of the original prescription is broken, resulting in a significant reduction in the anti-anxiety effect of the prescription. It can be seen that the compatibility of the present invention, "with Curcuma as the main drug, Gardenia and Semen Ziziphi Spinosae as the auxiliary drugs, Lotus seeds and Green Stone as the auxiliary drugs, and Chicken's Gizzard as the messenger", is a specific choice to achieve the anti-anxiety effect of the present invention, which cannot be achieved by other compatibility relationships.

[0080] Example 20 Clinical effect experiment

[0081] From March 2023 to March 2024, 63 patients with generalized anxiety disorder were observed in the Third Affiliated Hospital of Beijing University of Chinese Medicine. A randomized double-blind, parallel-controlled clinical design method was adopted. For patients with generalized anxiety who met the inclusion criteria, they were randomly divided into three groups: the Chinese medicine composition group of the present invention [the Chinese medicine composition granules of the present invention (prepared according to the method of Example 1) and paroxetine hydrochloride placebo], the control drug group [Chinese medicine placebo and paroxetine hydrochloride placebo], and the positive control drug group [paroxetine hydrochloride and Chinese medicine placebo], and the treatment lasted for 4 weeks. At weeks 0, 1, 2, and 4, the Hamilton Anxiety Rating Scale and the Chinese Medicine Syndrome Scale were used for efficacy evaluation, as well as safety evaluation.

[0082] 1. Research Plan

[0083] 1Diagnostic criteria and basis

[0084] 1.1 Diagnostic criteria for generalized anxiety disorder

[0085] Refer to the diagnostic criteria for generalized anxiety disorder in the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-V).

[0086] 1.2 TCM diagnostic criteria for generalized anxiety disorder: refer to the TCM Diseases and Syndromes Section of TCM Diagnosis and Treatment Guidelines for Common Diseases in Internal Medicine: Anxiety Disorder

[0087] 2 Inclusion criteria:

[0088] (1) Age 18 to 65 years old;

[0089] (2) meet the diagnostic criteria for generalized anxiety disorder;

[0090] (3) Vital signs are stable, the patient is conscious and has a certain ability to express himself. Only those who meet all three of the above conditions can be selected.

[0091] (4) junior high school education or above;

[0092] (5) No physical or endocrine diseases;

[0093] (6) Have sufficient audio-visual quality to complete the necessary examinations for the study;

[0094] (7) The patient and guardian agree and sign an informed consent form.

[0095] Exclusion criteria:

[0096] (1) Patients with unstable vital signs;

[0097] (2) Those with severe aphasia and agnosia who are unable to communicate;

[0098] (3) Those with certain schizophrenia symptoms;

[0099] (4) Anxiety patients diagnosed by Western medicine as suffering from other mental illnesses (such as obsessive-compulsive disorder, schizophrenia, etc.);

[0100] (5) There is evidence that anxiety is causally related to a physical illness;

[0101] (6) Patients with recurrent anxiety disorders;

[0102] (7) Known alcoholics or drug addicts;

[0103] Those who meet any of the above conditions will be excluded.

[0104] Elimination criteria:

[0105] ① After being selected, it was found that the patients did not meet the selection criteria for anxiety disorders and were mistakenly included;

[0106] ② Those who have not taken the trial drug once after enrollment;

[0107] ③ Those who seriously violate the experimental plan.

[0108] The reasons for excluding cases should be stated in the case report form.

[0109] Exit criteria:

[0110] ① If allergic reactions or serious adverse events occur, the clinical trial should be stopped according to the doctor's judgment, that is, the patient should withdraw from the clinical trial.

[0111] ② Those who withdraw their informed consent.

[0112] ③ Those who develop other serious diseases during the trial.

[0113] ④ Subjects whose blinding was broken during the trial.

[0114] ⑤Lost to follow-up.

[0115] ⑥ The subjects' compliance during medication was poor, with the amount of medication taken being less than 80% of the prescribed amount or exceeding 120% of the prescribed amount.

[0116] ⑦ During the medication process, prohibited drugs or treatments specified in the regimen were used.

[0117] ⑧ Becoming manic or showing obvious psychotic symptoms during the trial.

[0118] 3. Dosage Method

[0119] Weeks 1 to 4 (Days 0 to 28):

[0120] The Chinese medicine composition group of the present invention: taking the Chinese medicine composition granules of the present invention + paroxetine placebo in the morning and evening respectively;

[0121] Control group: taking Chinese medicine granule placebo + paroxetine placebo in the morning and evening respectively;

[0122] Positive control group: paroxetine + Chinese medicine granule placebo were taken in the morning and evening respectively.

[0123] The paroxetine hydrochloride placebo was made by mixing lactose and microcrystalline cellulose in a certain proportion and pressing them into tablets;

[0124] The Chinese medicine granule placebo was prepared by adding 10% of the Chinese medicine composition (Example 1) to granule excipients.

[0125] 4 Observation content, efficacy evaluation indicators and detection methods 4.1 Primary efficacy indicators: Hamilton Anxiety Rating Scale (HAMA) 4.2 Secondary efficacy indicators: Traditional Chinese Medicine Syndrome Scale (see Table 1).

[0126] Table 1 TCM syndrome scale for anxiety disorder

[0127]

[0128]

[0129] 4.3 Criteria for determining efficacy

[0130] 4.3.1 Scale reduction rate assessment:

[0131] Scale reduction rate = (pre-treatment score - post-treatment score) / pre-treatment score * 100%

[0132] The Hamilton Anxiety Rating Scale (HAMA) score reduction value was used to judge the improvement of the patient's anxiety; the Hamilton Anxiety Rating Scale (HAMA) score reduction rate ≥ 50% was judged as effective, and < 50% was judged as ineffective. The total score of the Hamilton Anxiety Rating Scale (HAMA) ≤ 7 after treatment was defined as anxiety recovery.

[0133] 4.3.2 Criteria for judging the efficacy of TCM syndromes

[0134] Therapeutic index n = (score before treatment - score after treatment) / score before treatment × 100%

[0135] Clinical control: clinical symptoms and signs disappear or almost disappear, and syndrome score decreases by ≥75%.

[0136] Markedly effective: Clinical symptoms and signs were significantly improved, and the syndrome score was reduced by ≥50% <75%.

[0137] Effective: Clinical symptoms and signs improved, and the syndrome score decreased by ≥50% <25%.

[0138] Ineffective: There is no significant improvement in clinical symptoms and signs, or they may even worsen, and the syndrome score decreases by less than 25%.

[0139] 5 Safety evaluation

[0140] Safety assessments will include vital signs, physical examinations, TESS, blood routine, urine routine, blood biochemistry, and electrocardiogram (ECG). Adverse events and serious adverse events will be recorded as other safety and tolerability indicators.

[0141] 6 Statistical methods

[0142] Descriptive statistics were used for data statistics. Measurement data were described by number of observations, mean, standard deviation, mode, maximum and minimum values, and count data were described by number of observations, frequency and percentage. Changes in MARS, HAMA and TCM syndrome scales were analyzed by covariance analysis, and adverse reactions were analyzed by descriptive statistics. All statistical tests were two-sided, and P values ​​less than or equal to 0.05 were considered to be statistically significant. SPSS18.0 statistical software package was used.

[0143] 2. Research Results

[0144] 1 General

[0145] A total of 63 subjects were included in this study, 1 dropped out and 2 were excluded. The reason for dropout was loss of follow-up, and there was no statistical difference between the two groups. The reasons for exclusion were all patients taking other drugs on their own. A total of 60 people completed clinical observation, including 21 males and 39 females. There were 19 cases in the Chinese medicine composition group of the present invention, 21 cases in the control drug group, and 20 cases in the positive control drug group.

[0146] 2 Main efficacy indicators

[0147] 2.1 Anxiety Improvement

[0148] There was no significant difference in the HAMA scale reduction rate among the three groups at week 1, but there were significant differences at week 2 and week 4. The anxiety efficacy of the Chinese medicine composition group of the present invention was 64% at week 2, the control group was 40%, and the positive control group was only 37%. The total effective rate of the Chinese medicine composition of the present invention at week 4 was 75.2%, the control group was 51%, and the positive control group was 69.1%, and there were significant differences among the three groups (P<0.05).

[0149] 2.2 TCM syndrome efficacy evaluation

[0150] The TCM syndrome efficacy indexes of the three groups were compared after 1, 2 and 4 weeks of treatment. At the end of the 4th week of the experiment, the average TCM syndrome efficacy index of the Chinese medicine combination group of the present invention was 78%, the average TCM syndrome efficacy index of the control drug group was 59%, and the average TCM syndrome efficacy index of the positive control drug group was 57.1%. The differences among the three groups were significant (P<0.05).

[0151] 2.3 Safety and adverse reactions evaluation

[0152] All patients in this study had no abnormalities in blood routine and liver and kidney function before and after treatment. Six patients in the western medicine group experienced mild dizziness, two experienced nausea, one experienced vomiting, and three experienced abdominal distension after taking the medicine. The Chinese medicine composition of the present invention and the control drug group did not have the above side effects.

[0153] 3. Research Conclusion

[0154] The results of this study show that the Chinese medicine composition of the present invention has the following advantages:

[0155] (1) Faster onset of effect: The anxiety efficacy of the Chinese medicine composition group in the second week was 64%, while that of the Western medicine group was only 37%. This shows that in terms of anti-anxiety, compared with the traditional Western medicine paroxetine hydrochloride, the Chinese medicine composition of the present invention has the characteristic of faster onset of effect.

[0156] (2) Good efficacy: At the end of the experiment, the total effective rate of the Chinese medicine composition of the present invention reached 75.2%, which was 6.1 percentage points higher than that of the anti-anxiety Western medicine paroxetine hydrochloride.

[0157] (3) Small side effects: Most antianxiety drugs have side effects such as dizziness, nausea and vomiting, abdominal distension and constipation, and weight gain, but the Chinese medicine composition group of the present invention did not produce the above symptoms.

Claims

1. A Chinese medicine composition for treating anxiety disorder, It is characterized in that The traditional Chinese medicine composition is prepared from turmeric, gardenia, lotus seeds, bluestone, chicken's gizzard lining and spiny jujube seeds.

2. The Chinese medicine composition according to claim 1, It is characterized in that The Chinese medicine composition is prepared from the following raw materials in parts by weight: 10-40 parts by weight of turmeric, 7-28 parts by weight of gardenia, 7-28 parts by weight of lotus seeds, 16-64 parts by weight of chloranthus, 4-18 parts by weight of chicken gizzard lining, and 16-64 parts by weight of spiny jujube seeds.

3. The Chinese medicine composition according to claim 2, It is characterized in that The Chinese medicine composition is prepared from the following raw materials in parts by weight: 15-30 parts by weight of turmeric, 10-20 parts by weight of gardenia, 10-20 parts by weight of lotus seeds, 22-44 parts by weight of chloranthus, 6-14 parts by weight of chicken gizzard lining, and 22-44 parts by weight of spiny jujube seeds.

4. The Chinese medicine composition according to claim 3, It is characterized in that The Chinese medicine composition is prepared from the following raw materials in parts by weight: 18-27 parts by weight of turmeric, 12-18 parts by weight of gardenia, 12-18 parts by weight of lotus seeds, 26-39 parts by weight of chloranthus, 8-12 parts by weight of chicken gizzard lining, and 26-39 parts by weight of spiny jujube seeds.

5. The Chinese medicine composition according to claim 4, It is characterized in that The Chinese medicine composition is prepared from the following raw materials in parts by weight: 20 parts by weight of turmeric, 15 parts by weight of gardenia, 15 parts by weight of lotus seeds, 30 parts by weight of chloranthus, 10 parts by weight of chicken gizzard lining, and 30 parts by weight of spiny jujube seeds.

6. The Chinese medicine composition according to any one of claims 1 to 5, It is characterized in that The Chinese medicine composition is a composition obtained by mixing the raw materials after crushing, or an extract obtained by mixing or extracting the raw materials separately, or an effective part obtained by further refining and purifying the extract, or a conventional dosage form prepared by adding pharmaceutically acceptable excipients to the extract / effective part.

7. A Chinese medicine composition for treating anxiety disorder, It is characterized in that The Chinese medicine composition is prepared from the following raw materials: 10-40 parts by weight of Curcuma extract, 7-28 parts by weight of Gardenia extract, 7-28 parts by weight of Lotus seed extract, 16-64 parts by weight of Celadon extract, 4-18 parts by weight of Chicken Gizzard Extract, and 16-64 parts by weight of Ziziphus jujuba seed extract; Wherein, the extracts are water extracts of respective raw materials.

8. The Chinese medicine composition according to claim 7, It is characterized in that The Chinese medicine composition is prepared from the following raw materials in parts by weight: 15-30 parts by weight of turmeric extract, 10-20 parts by weight of gardenia extract, 10-20 parts by weight of lotus seed extract, 22-44 parts by weight of celery extract, 6-14 parts by weight of chicken gizzard lining extract, and 22-44 parts by weight of spiny jujube seed extract.

9. The Chinese medicine composition according to claim 8, It is characterized in that The Chinese medicine composition is prepared from the following raw materials in parts by weight: 20 parts by weight of Curcuma extract, 15 parts by weight of Gardenia extract, 15 parts by weight of Lotus seed extract, 30 parts by weight of Celadonite extract, 10 parts by weight of Chicken Gizzard Stone Extract, and 30 parts by weight of Ziziphus jujuba seed extract.

10. Use of the Chinese medicine composition according to any one of claims 1-5 and 7-9 in the preparation of a medicament for treating anxiety.

Citation Information

Patent Citations

  • Method for evaluating effectiveness and safety of anti-depression traditional Chinese medicine composition in treating mild / moderate depression

    CN103230602A

  • Natural composition for treating depression and preparation method thereof

    CN109432362A

  • Anti-anxiety traditional Chinese medicine composition as well as preparation method and application thereof

    CN114949148A